{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:03:49Z","timestamp":1789038229878,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109137","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:03:01Z","timestamp":1761181381000},"page":"109137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Newly synthesized ethenyl pyridazines and ethenyl pyridazinones as anti-inflammatory agents with COVID-19 suppressing potential"],"prefix":"10.1016","volume":"166","author":[{"given":"Eman M.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia A.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha H.","family":"Emam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila A.","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma A.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirvana A.","family":"Gohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109137_bb0005","article-title":"Severe COVID-19 pneumonia: pathogenesis and clinical management","volume":"372","author":"Attaway","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109137_bb0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.rxeng.2020.11.002","article-title":"Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications","volume":"63","author":"Gordo","year":"2021","journal-title":"Radiolog\u00eda (Engl. Ed.)"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109137_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/thoraxjnl-2020-216088","article-title":"Severe organising pneumonia following COVID-19","volume":"76","author":"Vad\u00e1sz","year":"2021","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109137_bb0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/medicina58020144","article-title":"Cytokine storm in COVID-19: immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.bioorg.2025.109137_bb0025","article-title":"Cytokine storm: the primary determinant for the pathophysiological evolution of COVID-19 deterioration","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2025.109137_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cytogfr.2020.12.005","article-title":"The cytokine storm in COVID-19: further advances in our understanding the role of specific chemokines involved","volume":"58","author":"Coperchini","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109137_bb0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/covid2050040","article-title":"The cytokine storm in COVID-19: the strongest link to morbidity and mortality in the current epidemic","volume":"2","author":"Basheer","year":"2022","journal-title":"COVID"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109137_bb0040","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7150\/thno.49713","article-title":"Immunopathogenesis and treatment of cytokine storm in COVID-19","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109137_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41581-022-00642-4","article-title":"Therapeutic advances in COVID-19","volume":"19","author":"Murakami","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"23","key":"10.1016\/j.bioorg.2025.109137_bb0050","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109137_bb0055","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00014-21","article-title":"Nonsteroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection","volume":"95","author":"Chen","year":"2021","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109137_bb0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10787-022-00993-1","article-title":"A raising dawn of pentoxifylline in management of inflammatory disorders in COVID-19","volume":"30","author":"Mostafa-Hedeab","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109137_bb0065","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/jcm14030882","article-title":"Exploring anti-inflammatory treatment as upstream therapy in the management of atrial fibrillation","volume":"14","author":"Zheng","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109137_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/biomed3010015","article-title":"Early multi-target treatment of mild-to-moderate COVID-19, particularly in terms of non-steroidal anti-inflammatory drugs and indomethacin","volume":"3","author":"Fazio","year":"2023","journal-title":"BioMed"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109137_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13797","article-title":"Sulfated polysaccharides as multi target molecules to fight COVID-19 and comorbidities","volume":"9","author":"Carvajal-Barriga","year":"2023","journal-title":"Heliyon"},{"issue":"19","key":"10.1016\/j.bioorg.2025.109137_bb0080","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1080\/07391102.2021.1931451","article-title":"Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications","volume":"40","author":"Naik","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109137_bb0085","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/ddr.22118","article-title":"Pyridazine derivatives as selective COX-2 inhibitors: a review on recent updates","volume":"84","author":"Ewieda","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2025.109137_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107623","article-title":"Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives","volume":"150","author":"Ewieda","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109137_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22173","article-title":"Pyridazine and pyridazinone derivatives: synthesis and in vitro investigation of their anti-inflammatory potential in LPS-induced RAW264.7 macrophages","volume":"85","author":"Osman","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109137_bb0100","first-page":"2692","volume":"15","author":"Osman","year":"2024","journal-title":"Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109137_bb0105","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.3390\/molecules27123749","article-title":"Pyridazinones and structurally related derivatives with anti-inflammatory activity","volume":"27","author":"Cantini","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109137_bb0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1573406419666230913102835","article-title":"Diverse pharmacological potential of pyridazine analogs against various diseases","volume":"20","author":"Alsaiari","year":"2024","journal-title":"Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109137_bb0115","article-title":"Molecular properties prediction, anticancer and anti-inflammatory activities of some pyrimido[1, 2-b]pyridazin-2-one derivatives","volume":"14","author":"Zeiz","year":"2023","journal-title":"BioImpacts"},{"issue":"17","key":"10.1016\/j.bioorg.2025.109137_bb0120","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1021\/acs.jmedchem.3c00832","article-title":"Discovery of the diphenyl 6-oxo-1,6-dihydropyridazine-3-carboxylate\/carboxamide analogue J27 for the treatment of acute lung injury and sepsis by targeting JNK2 and inhibiting the JNK2-NF-\u03baB\/MAPK pathway","volume":"66","author":"Liao","year":"2023","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2025.109137_bb0125","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.3390\/molecules26175319","article-title":"Imidazopyridazine acetylcholinesterase inhibitors display potent anti-proliferative effects in the human neuroblastoma cell-line, IMR-32","volume":"26","author":"Sharma","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109137_bb0130","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.3390\/ijms26083806","article-title":"Therapeutic potential of tricyclic pyridazinone-based molecules: an overview","volume":"26","author":"Asproni","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109137_bb0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1570193X19666220329155551","article-title":"A mini-review on pyridazine analogs: chemical and pharmacological potentials","volume":"20","author":"Alghamdi","year":"2023","journal-title":"Mini-Rev. Organic Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2025.109137_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411518","article-title":"PDE4 inhibitors: profiling hits through the multitude of structural classes","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109137_bb0145","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.3390\/ijms23137226","article-title":"Inhibition of recruitment and activation of neutrophils by pyridazinone-scaffold-based compounds","volume":"23","author":"Moniot","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109137_bb0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4155\/fmc-2017-0144","article-title":"Facile synthesis of some pyrazoline-based compounds with promising anti-inflammatory activity","volume":"10","author":"Eid","year":"2018","journal-title":"Future Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.109137_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2011.08.007","article-title":"Role of \u03b17 nicotinic acetylcholine receptors in regulating tumor necrosis factor-\u03b1 (TNF-\u03b1) as revealed by subtype selective agonists","volume":"239","author":"Li","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109137_bb0160","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1021\/acs.jmedchem.3c00359","article-title":"Design, synthesis, and bioevaluation of novel MyD88 inhibitor c17 against acute lung injury derived from the virtual screen","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"issue":"7\u20138","key":"10.1016\/j.bioorg.2025.109137_bb0165","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0223-5234(96)88278-X","article-title":"New pyridazinone derivatives as inhibitors of platelet aggregation","volume":"30","author":"Corsano","year":"1995","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109137_bb0170","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1021\/jm00114a010","article-title":"New 5H-pyridazino[4,5-b]indole derivatives. Synthesis and studies as inhibitors of blood platelet aggregation and inotropics","volume":"34","author":"Monge","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109137_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156291","article-title":"Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders","volume":"170","author":"Bhattacharjee","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.bioorg.2025.109137_bb0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00068-001-1324-z","article-title":"Immune reactions after trauma","volume":"29","author":"van Griensven","year":"2003","journal-title":"Eur. J. Trauma"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109137_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253894","article-title":"Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis","volume":"16","author":"Melo","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109137_bb0190","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S2213-2600(21)00103-X","article-title":"Interleukin-6: obstacles to targeting a complex cytokine in critical illness","volume":"9","author":"McElvaney","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bioorg.2025.109137_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113107","article-title":"Immune-based therapeutic approaches in COVID-19","volume":"151","author":"Moeinafshar","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.109137_bb0200","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2025.109137_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109137_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109137_bb0215","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2021.04.019","article-title":"Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis-first update","volume":"27","author":"Tleyjeh","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109137_bb0220","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1016\/j.bmc.2008.04.007","article-title":"Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity","volume":"16","author":"Abouzid","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109137_bb0225","first-page":"19","article-title":"Pyridazinones and pyrrolones as promising scaffolds in medicinal chemistry","volume":"2","author":"Abdelbaset","year":"2019","journal-title":"JABPS"},{"key":"10.1016\/j.bioorg.2025.109137_bb0230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejmech.2019.03.036","article-title":"Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents","volume":"171","author":"Ahmed","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109137_bb0235","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ardp.200300778","article-title":"Investigations of new pyridazinone derivatives for the synthesis of potent analgesic and anti-inflammatory compounds with cyclooxygenase inhibitory activity","volume":"336","author":"\u00d6k\u00e7elik","year":"2003","journal-title":"Arch. Pharm."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109137_bb0240","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1590\/S1984-82502013000400030","article-title":"Analgesic and anti-inflammatory activities of several 4-substituted-6-(3\u2032-nitrophenyl)pyridazin-(2H)-3-one derivatives","volume":"49","author":"Singh","year":"2013","journal-title":"Br. J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109137_bb0245","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/cber.19560890226","article-title":"\u00dcber die kondensation von l\u00e4vulins\u00e4ure mit aromatischen aldehyden","volume":"89","author":"Zaheer","year":"1956","journal-title":"Chemische Berichte"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109137_bb0250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ardp.19943270207","article-title":"Synthesis of antitumour carbon-bridged imidazopyridazine carbamates","volume":"327","author":"Denyer","year":"1994","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109137_bb0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bioorg.2014.08.006","article-title":"Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as histone deacetylase inhibitors and cytotoxic agents","volume":"57","author":"Abdel-Atty","year":"2014","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109137_bb0260","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1134\/S1070363213100113","article-title":"Synthesis, structure and chemical transformations of 4-aminobenzaldehyde","volume":"83","author":"Nurkenov","year":"2013","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.bioorg.2025.109137_bb0265","unstructured":"R. Jonas, J. Piulats, 6-Arylalkenylpyridazinones, Merck Patent GmbH (1987), DE3527036A1."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109137_bb0270","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/jm900592h","article-title":"6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors","volume":"52","author":"Cilibrizzi","year":"2009","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109137_bb0275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ddr.21076","article-title":"Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists","volume":"74","author":"Crocetti","year":"2013","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2025.109137_bb0280","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ejmech.2013.03.066","article-title":"Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists","volume":"64","author":"Givoannoni","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109137_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103497","article-title":"New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation","volume":"95","author":"Ahmed","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109137_bb0290","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/molecules25071624","article-title":"Silacyclohexanes, Sila(hetero)cyclohexanes and related compounds: structure and conformational analysis","volume":"25","author":"Shainyan","year":"2020","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.bioorg.2025.109137_bb0295","doi-asserted-by":"crossref","first-page":"12769","DOI":"10.1021\/acsomega.1c01093","article-title":"The 1H NMR spectroscopic effect of steric compression is found in [3.3.1]oxa- and azabicycles and their analogues","volume":"6","author":"Zeng","year":"2021","journal-title":"ACS Omega"},{"issue":"29","key":"10.1016\/j.bioorg.2025.109137_bb0300","doi-asserted-by":"crossref","first-page":"19465","DOI":"10.1039\/C5CP02400E","article-title":"Stereochemical modulation of emission behaviour in E\/Z isomers of diphenyldipyrroethene from aggregation induced emission to crystallization induced emission","volume":"17","author":"Garg","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109137_bb0305","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1039\/p29960000333","article-title":"Substituent chemical shifts in NMR spectroscopy. Part 6. A model for the calculation of proton chemical shifts in substituted alkanes","volume":"2","author":"Abraham","year":"1996","journal-title":"J. Chem. Soc. Perkin Trans."},{"issue":"43","key":"10.1016\/j.bioorg.2025.109137_bb0310","doi-asserted-by":"crossref","first-page":"15385","DOI":"10.1039\/D0DT03018J","article-title":"Two new monofunctional platinum (II) dithiocarbamate complexes: phenanthriplatin-type axial protection, equatorial-axial conformational isomerism, and anticancer and DNA binding studies","volume":"49","author":"Imran","year":"2020","journal-title":"Dalton Trans."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109137_bb0315","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/molecules22010148","article-title":"Synthesis of some new pyridazine derivatives for anti-HAV evaluation","volume":"22","author":"Flefel","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109137_bb0320","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00044-012-0099-6","article-title":"4-Substitutedphthalazines and phthalazinones: synthesis, characterization and \u03b2-adrenergic blocking activity","volume":"22","author":"Abouzid","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.109137_bb0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00908906","article-title":"\u00dcber pyridazine mit kerngebundenem chlor","volume":"99","author":"Schiinbeck","year":"1968","journal-title":"Monatshefte fuer Chemie"},{"key":"10.1016\/j.bioorg.2025.109137_bb0330","series-title":"Prototropic tautomerism of heteroaromatic compounds, chapter 6 in: advances in heterocyclic chemistry","first-page":"311","volume":"vol. 1","author":"Katritzky","year":"1963"},{"key":"10.1016\/j.bioorg.2025.109137_bb0335","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10822-009-9303-2","article-title":"Let\u2019s not forget tautomers","volume":"23","author":"Martin","year":"2009","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2025.109137_bb0340","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.chemphys.2012.09.019","article-title":"Studies of the tautomeric equilibrium of 1,3-thiazolidine-2-thione: theoretical and experimental approaches","volume":"408","author":"Abbehausen","year":"2012","journal-title":"Chem. Phys."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109137_bb0345","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1016\/S0040-4020(01)87905-9","article-title":"Alkoxynitrenium ion cyclisations: evidence for different mechanisms in the formation of benzoxazines and benzoxazepines","volume":"46","author":"Glover","year":"1990","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.109137_bb0350","series-title":"A Dynamic NMR Investigation of the Conformational Isomerism in Novel 1,3,4,5-Tetrahydro-2,1-Benzoxazepines, Conference of Department of Chemistry","author":"Banks","year":"1996"},{"key":"10.1016\/j.bioorg.2025.109137_bb0355","series-title":"Atropisomers: fundamentals, Pharmaceutical Considerations, & Selective Syntheses","author":"Metrano","year":"2018"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109137_bb0360","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41557-022-01004-0","article-title":"The ribosome stabilizes partially folded intermediates of a nascent multi-domain protein","volume":"14","author":"Chan","year":"2022","journal-title":"Nat. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109137_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183807","article-title":"New carboxamide derivatives bearing benzenesulphonamide as a selective COX-II inhibitor: design, synthesis and structure-activity relationship","volume":"12","author":"Ugwu","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109137_bb0370","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.7401","article-title":"Gold(I) N-heterocyclic carbene (NHC) complexes containing 6-mercaptopurine derivatives and their in vitro anticancer and anti-inflammatory effects","volume":"38","author":"Tr\u00e1vn\u00ed\u010dek","year":"2024","journal-title":"Appl. Organomet. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109137_bb0375","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1039\/c3fo30376d","article-title":"Inhibitory effects of medicinal mushrooms on \u03b1-amylase and \u03b1-glucosidase\u2013enzymes related to hyperglycemia","volume":"4","author":"Su","year":"2013","journal-title":"Food Funct."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109137_bb0380","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3109\/09553002.2011.602378","article-title":"Anti-ulcerogenic effect of aqueous propolis extract and the influence of radiation exposure","volume":"87","author":"El-Ghazaly","year":"2011","journal-title":"Int. J. Radiat. Biol."},{"issue":"2\u20133","key":"10.1016\/j.bioorg.2025.109137_bb0385","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jep.2003.09.003","article-title":"Study of Mimusops elengi bark in experimental gastric ulcers","volume":"89","author":"Shah","year":"2003","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.109137_bb0390","first-page":"628","article-title":"Comparative evaluation of the anti-ulcer activity of curcumin and omeprazole during the acute phase of gastric ulcer\u2014efficacy of curcumin in gastric ulcer prevention against omeprazole","volume":"2","author":"Karolin Kamel","year":"2011","journal-title":"Food Nutr. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109137_bb0395","doi-asserted-by":"crossref","first-page":"339","DOI":"10.33899\/ijvs.2022.134659.2389","article-title":"Pathological and histomorphometric study of comparative gastric ulcer induced by indomethacin, aspirin, and ethanol in rats","volume":"37","author":"Saeed","year":"2023","journal-title":"Iraqi J. Vet. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:08:18Z","timestamp":1763665698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682501017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":79,"alternative-id":["S004520682501017X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109137","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newly synthesized ethenyl pyridazines and ethenyl pyridazinones as anti-inflammatory agents with COVID-19 suppressing potential","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109137"}}